» Articles » PMID: 26185090

The Biology of the Escherichia Coli Extracellular Matrix

Overview
Specialty Microbiology
Date 2015 Jul 18
PMID 26185090
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Escherichia coli is one of the world's best-characterized organisms, because it has been extensively studied for over a century. However, most of this work has focused on E. coli grown under laboratory conditions that do not faithfully simulate its natural environments. Therefore, the historical perspectives on E. coli physiology and life cycle are somewhat skewed toward experimental systems that feature E. coli growing logarithmically in a test tube. Typically a commensal bacterium, E. coli resides in the lower intestines of a slew of animals. Outside of the lower intestine, E. coli can adapt and survive in a very different set of environmental conditions. Biofilm formation allows E. coli to survive, and even thrive, in environments that do not support the growth of planktonic populations. E. coli can form biofilms virtually everywhere: in the bladder during a urinary tract infection, on in-dwelling medical devices, and outside of the host on plants and in the soil. The E. coli extracellular matrix (ECM), primarily composed of the protein polymer named curli and the polysaccharide cellulose, promotes adherence to organic and inorganic surfaces and resistance to desiccation, the host immune system, and other antimicrobials. The pathways that govern E. coli biofilm formation, cellulose production, and curli biogenesis will be discussed in this article, which concludes with insights into the future of E. coli biofilm research and potential therapies.

Citing Articles

Co-Existence Slows Diversification in Experimental Populations of E. coli and P. fluorescens.

Howells G, Sezmis A, Blake C, McDonald M Environ Microbiol. 2025; 27(2):e70061.

PMID: 39988434 PMC: 11847636. DOI: 10.1111/1462-2920.70061.


Spatial propagation of temperate phages within and among biofilms.

Winans J, Zeng L, Nadell C Proc Natl Acad Sci U S A. 2025; 122(6):e2417058122.

PMID: 39903123 PMC: 11831127. DOI: 10.1073/pnas.2417058122.


Biofilm Formation by Isolated from Urinary Tract Infections from Aguascalientes, Mexico.

Ramirez Castillo F, Barrera A, Harel J, Avelar Gonzalez F, Vogeleer P, Arreola Guerra J Microorganisms. 2023; 11(12).

PMID: 38138002 PMC: 10745304. DOI: 10.3390/microorganisms11122858.


Alzheimer's Progenitor Amyloid-β Targets and Dissolves Microbial Amyloids and Impairs Biofilm Function.

Ali S, Karen Chung K, Forgham H, Olsen W, Kakinen A, Balaji A Adv Sci (Weinh). 2023; 10(29):e2301423.

PMID: 37594661 PMC: 10582422. DOI: 10.1002/advs.202301423.


Regulation by cyclic di-GMP attenuates dynamics and enhances robustness of bimodal curli gene activation in Escherichia coli.

Lamprecht O, Ratnikava M, Jacek P, Kaganovitch E, Buettner N, Fritz K PLoS Genet. 2023; 19(5):e1010750.

PMID: 37186613 PMC: 10212085. DOI: 10.1371/journal.pgen.1010750.


References
1.
Gualdi L, Tagliabue L, Landini P . Biofilm formation-gene expression relay system in Escherichia coli: modulation of sigmaS-dependent gene expression by the CsgD regulatory protein via sigmaS protein stabilization. J Bacteriol. 2007; 189(22):8034-43. PMC: 2168689. DOI: 10.1128/JB.00900-07. View

2.
Cegelski L, Pinkner J, Hammer N, Cusumano C, Hung C, Chorell E . Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol. 2009; 5(12):913-9. PMC: 2838449. DOI: 10.1038/nchembio.242. View

3.
Beloin C, Roux A, Ghigo J . Escherichia coli biofilms. Curr Top Microbiol Immunol. 2008; 322:249-89. PMC: 2864707. DOI: 10.1007/978-3-540-75418-3_12. View

4.
Danese P, Pratt L, Kolter R . Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J Bacteriol. 2000; 182(12):3593-6. PMC: 101973. DOI: 10.1128/JB.182.12.3593-3596.2000. View

5.
Kaper J, Nataro J, Mobley H . Pathogenic Escherichia coli. Nat Rev Microbiol. 2004; 2(2):123-40. DOI: 10.1038/nrmicro818. View